- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.10. | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care Surpasses 3,000 Treatments Performed Worldwide | 91 | GlobeNewswire (Europe) | Scandinavian ChemoTech's Animal Care, a pioneer in making oncology care more compassionate and human for animals, proudly announces another achievement: over 3,000 treatments have now been performed... ► Artikel lesen | |
| 01.10. | Scandinavian ChemoTech AB: ChemoTech's Animal Care Reports Strong Q3 Sales, Surpassing Expectations Despite Seasonal Slowdown | 82 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB's Animal Care division is proud to announce another strong quarter, generating sales of USD 340,000 in Q3 2025. This result is within USD 50,000 of the company's record-breaking... ► Artikel lesen | |
| 26.09. | Scandinavian ChemoTech AB: ChemoTech's Animal Care Successfully Enters Swiss Market as Part of DACH Expansion | 430 | GlobeNewswire (Europe) | Scandinavian ChemoTech and its subsidiary VQ Animal Care Inc. is pleased to announce that it has officially started marketing vetIQure, its Tumor Specific Electroporation (TSE) technology in Switzerland.... ► Artikel lesen | |
| 19.09. | Scandinavian ChemoTech Hosts Successful TSE Best Practice Sharing Session with Dr. Brendan Boostrom | 1 | Cision News | ||
| SCANDINAVIAN CHEMOTECH Aktie jetzt für 0€ handeln | |||||
| 10.09. | Scandinavian ChemoTech AB: ChemoTech Expands in Illinois as 8th Clinic within Major U.S. Veterinary Group Adopts TSE Technology | 74 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB today announced that its veterinary subsidiary, VQ Animal Care Inc., has secured a new partnership in Illinois. With this latest order, the eighth clinic within one of the... ► Artikel lesen | |
| 25.08. | Scandinavian ChemoTech Expands in Florida with Fourth Veterinary Oncology Clinic Partnership | 2 | Cision News | ||
| 20.08. | Scandinavian ChemoTech's Animal Care Surpasses 2,500 Treatment-kits sold Worldwide | 2 | Cision News | ||
| 12.08. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q2 2025 | 120 | GlobeNewswire (Europe) | Second quarter sales reached 3,841 KSEK, which is the best quarter so far. All sales originated from Animal Care. The report is attached to this press release and can also be downloaded from the company's... ► Artikel lesen | |
| 29.07. | Scandinavian ChemoTech Welcomes Strategic Investors from the announce Directed Share Issue to Accelerate Global Growth | 2 | Cision News | ||
| 27.07. | Scandinavian ChemoTech AB (publ) carries out a directed share issue and receives approximately 4.85 MSEK | 2 | Cision News | ||
| 25.07. | (RETRANS) Scandinavian ChemoTech's TSE Treatment Shows High Response Rate in Veterinary Cancer Study - Validated by Approved PhD Dissertation | 1 | Cision News | ||
| 24.07. | Scandinavian ChemoTech's TSE Treatment Shows High Response Rate in Veterinary Cancer Study - Validated by Approved PhD Dissertation | 1 | Cision News | ||
| 01.07. | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care Division Achieves Record-Breaking Sales in Q2 2025 | 139 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB's Animal Care division proudly announces record-breaking sales in the second quarter of 2025. With continued momentum from a strong start to the quarter, the team achieved... ► Artikel lesen | |
| 06.05. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q1 2025 | 131 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB (publ) hereby publishes the Interim Report for Q1 2025.
First-quarter sales reached 2 472 KSEK, which is the best quarter so far. All sales originated from Animal Care.
First... ► Artikel lesen | |
| 04.03. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Year-End Report January - December 2024 | 148 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB (publ) hereby publishes the Year-End Report for 2024.
Fourth-quarter sales reached 2 041 KSEK, which is the best quarter in 2024. Total annual sales amounted to 6 566 KSEK-entirely... ► Artikel lesen | |
| 30.01. | Scandinavian ChemoTech AB: Scandinavian ChemoTech Restructures Loans and Doubles the Duration to 12 Months | 204 | GlobeNewswire (Europe) | ChemoTech is pleased to announce the signing of new restructured loan agreements to replace its previous short-term bridge financing. The new agreements include a 2.4 MSEK loan from two external investors... ► Artikel lesen | |
| 24.01. | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care operations showed positive cashflow for 2024 in separate reporting | 222 | GlobeNewswire (Europe) | Scandinavian ChemoTech is pleased to announce that our Animal Care operations would already be showing a positive cash flow if we reported our business areas separately. This underscores the importance... ► Artikel lesen | |
| 09.01. | Scandinavian ChemoTech AB: Scandinavian ChemoTech Implements Management Changes to Reduce Costs and Boost Revenues | 171 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB, in line with the structural changes for the group published on December 30, 2024, has decided to implement measures aimed at achieving financial sustainability. As part of... ► Artikel lesen | |
| 30.12.24 | Scandinavian ChemoTech AB: Scandinavian ChemoTech Splits Business Units to Boost Cash Flow and will suggest a new name for the group | 224 | GlobeNewswire (Europe) | Since 2021, Scandinavian ChemoTech has operated two distinct business units - Human Care and Animal Care. While Human Care was the group's initial focus, the Board of Directors has made key decisions... ► Artikel lesen | |
| 29.11.24 | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care division is heading for a strong fourth quarter 2024 in terms of sales | 155 | GlobeNewswire (Europe) | Animal Care is on track to close 2024 on a high note, with sales in the fourth quarter already reaching approximately 1,500 KSEK and projected to surpass 6,000 KSEK for the full year. This highlights... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 33,500 | 0,00 % | Jefferies hebt Kursziel für BrightSpring Health wegen starker Fundamentaldaten auf 36 US-Dollar an | ||
| FRESENIUS | 48,970 | +1,43 % | DAX stabil, Gold mit neuem Hoch: AMD, Sartorius, Merck, BASF, Rheinmetall, Fresenius im Fokus | Der DAX hat zur Wochenmitte leicht nachgegeben. Am Mittwoch ging der deutsche Leitindex 0,2 Prozent tiefer bei 24.181,37 Zählern aus dem Handel. Am Dienstag notierte der DAX noch zeitweise unter der... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 46,490 | -1,44 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 49,360 | +0,04 % | PRESSESPIEGEL/Unternehmen: KUNUNU, DEUTSCHE BANK, SIEMENS HEALTHINEERS, WIRECARD, SUPER 8 | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
KUNUNU - Die Arbeitgeber-Bewertungsplattform Kununu steht vor einem Eigentümerwechsel.... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 17,290 | -0,66 % | Alignment Healthcare USA, LLC: Alignment Health Plan Joins Forces with Suvida Healthcare to Expand Bilingual Care, Access for Arizona Seniors | ||
| GERRESHEIMER | 27,940 | +0,87 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
16.10.2025 / 17:50 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 47,220 | -0,30 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec auf "Underweight" mit einem Kursziel von 35,10 Euro belassen. Anchal Verma sieht in einer am Freitag vorliegenden... ► Artikel lesen | |
| PICARD MEDICAL | 13,270 | 0,00 % | Picard Medical, Inc.: Picard Medical Reports Second Quarter 2025 Financial Results | Strong commercial momentum driven by higher product sales - Total revenue and $19.5 million IPO proceeds support expansion and innovation in artificial heart technology - TUSCON, Ariz., Sept. 15,... ► Artikel lesen | |
| OTTOBOCK | 69,20 | +3,21 % | Ottobock-Aktie im Fokus - Anleger setzen auf Innovationen und starkes Wachstum im MedTech-Sektor! | ||
| HEARTFLOW | 39,910 | +1,54 % | Heartflow, Inc.: New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning | ||
| UNITEDHEALTH | 310,10 | -0,05 % | UnitedHealth: Zu viel Optimismus? | Die Aktie des größten US-amerikanischen Krankenversicherers hat sich in den zurückliegenden Wochen zwar deutlich von den Mehrjahrestiefs nach oben lösen können. Allerdings notiert der Titel immer noch... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 5,140 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Second Quarter 2025 Results | SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| KINDLY MD | 0,795 | 0,00 % | B. Riley starts coverage of Bitmine, SharpLink, FG Nexus, Kindly MD, Sequans with Buy ratings | ||
| INTUITIVE SURGICAL | 475,00 | +0,07 % | Vor den Zahlen: Intuitive Surgical: Jetzt Rebound-Chance vor den Earnings? | © Foto: Christian Charisius/dpaIntuitive Surgical ist ein innovatives US-Unternehmen und arbeitet im Bereich robotergestützter Chirurgie erfolgreich. Doch die Aktie ließ zuletzt Federn. Am Dientag sind... ► Artikel lesen | |
| HIMS & HERS HEALTH | 41,840 | +0,22 % | GRAIL-Aktie dreht schon wieder auf: Krebserkennungstest verblüfft - Hims & Hers investiert | Der positive Newsflow beim US-amerikanischen Krebsdiagnostik-Spezialisten GRAIL reißt nicht ab. Weitere Daten zum Bluttest zur Früherkennung mehrerer Krebsarten (Name: Galleri) unterstreichen den positiven... ► Artikel lesen |
SCANDINAVIAN CHEMOTECH AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,381 Euro und damit -2,81 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCANDINAVIAN CHEMOTECH AB finden Sie auf Wallstreet Online.